knowledge -WSS

knowledge

author：comprehensive 2025-10-01 11:46:24 - browse：291

U.S. President Joe Biden stands with his fingers locked next to an US flag — politics coverage from STAT — President Biden's White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs.

WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year.

The news is not controversial: The pharmaceutical companies that make the first ten drugs up for negotiation all submitted counteroffers. It’s an incremental step in the new program, which was created in 2022.

Earlier this year, Medicare sent its initial price offers to the companies. Neither the Biden administration nor the drug manufacturers have volunteered any information about the White House’s initial price offers or the counteroffers. The process is scheduled to end by Aug. 1.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Medicare innovation center doesn’t save money, experts say

WSS

New oral drug delivery patch is modeled after octopus tentacles

European officials brace for rough respiratory virus season

Judge rejects Trump's request to move Stormy Daniels hush

Health insurers' Q3 question: how much care are people getting?

WHO recommends second malaria vaccine

Medicare innovation center doesn’t save money, experts say

hotspot

knowledge

explore

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Medicare proposal to cover medical devices draws a mixed reaction

Study points to new risk in gene therapy death of Terry Horgan

Activists slam private health insurers over coverage restrictions

I learned firsthand about improving diversity in clinical trials

Jerome Adams on the need for new antivirals for Covid

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

What does generative AI mean for health care? We asked experts

New oral drug delivery patch is modeled after octopus tentacles

entertainment

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Divers poised to search for children washed away in Pennsylvania flash flood

Judge rejects Trump's request to move Stormy Daniels hush

WHO recommends second malaria vaccine

EF3 tornado rips through North Carolina amid extreme weather nationwide

Affordable Connectivity Program vital to health care, experts say

entertainment

hotspot

knowledge

knowledge